Iconovo (ICO) - Net Assets

Latest as of December 2025: Skr117.92 Million SEK ≈ $12.69 Million USD

Based on the latest financial reports, Iconovo (ICO) has net assets worth Skr117.92 Million SEK (≈ $12.69 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr131.08 Million ≈ $14.11 Million USD) and total liabilities (Skr13.16 Million ≈ $1.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Iconovo to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr117.92 Million
% of Total Assets 89.96%
Annual Growth Rate 34.1%
5-Year Change -13.95%
10-Year Change 1250.77%
Growth Volatility 80.35

Iconovo - Net Assets Trend (2015–2025)

This chart illustrates how Iconovo's net assets have evolved over time, based on quarterly financial data. Also explore Iconovo balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Iconovo (2015–2025)

The table below shows the annual net assets of Iconovo from 2015 to 2025. For live valuation and market cap data, see ICO market cap.

Year Net Assets Change
2025-12-31 Skr117.92 Million
≈ $12.69 Million		 -8.74%
2024-12-31 Skr129.21 Million
≈ $13.91 Million		 +13.82%
2023-12-31 Skr113.53 Million
≈ $12.22 Million		 +27.14%
2022-12-31 Skr89.29 Million
≈ $9.61 Million		 -34.84%
2021-12-31 Skr137.03 Million
≈ $14.75 Million		 +47.78%
2020-12-31 Skr92.73 Million
≈ $9.98 Million		 -14.77%
2019-12-31 Skr108.79 Million
≈ $11.71 Million		 +70.03%
2018-12-31 Skr63.99 Million
≈ $6.89 Million		 +102.97%
2017-12-31 Skr31.52 Million
≈ $3.39 Million		 +261.10%
2016-12-31 Skr8.73 Million
≈ $939.49K		 +39.26%
2015-12-31 Skr6.27 Million
≈ $674.65K		 --

Equity Component Analysis

This analysis shows how different components contribute to Iconovo's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 23371601400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock Skr5.31 Million 4.50%
Other Components Skr347.18 Million 294.42%
Total Equity Skr117.92 Million 100.00%

Iconovo Competitors by Market Cap

The table below lists competitors of Iconovo ranked by their market capitalization.

Company Market Cap
COINSILIUM GROUP LTD
F:5CT
 $6.94 Million
Commerce Split Corp
TO:YCM
 $6.94 Million
Sonoro Energy Ltd
V:SNV
 $6.94 Million
Canadian Premium Sand Inc
V:CPS
 $6.95 Million
M3-Brigade Acquisition V Corp. Warrant
NASDAQ:MBAVW
 $6.94 Million
FD Technologies Plc
LSE:FDP
 $6.93 Million
Tapaco Public Company Limited
BK:TAPAC
 $6.93 Million
Cambridge Technology Enterprises Limited
NSE:CTE
 $6.93 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Iconovo's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 129,212,000 to 117,922,000, a change of -11,290,000 (-8.7%).
  • Net loss of 43,364,000 reduced equity.
  • Share repurchases of 36,612,000 reduced equity.
  • New share issuances of 36,612,000 increased equity.
  • Other factors increased equity by 32,074,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr-43.36 Million -36.77%
Share Repurchases Skr36.61 Million -31.05%
Share Issuances Skr36.61 Million +31.05%
Other Changes Skr32.07 Million +27.2%
Total Change Skr- -8.74%

Book Value vs Market Value Analysis

This analysis compares Iconovo's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.39x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.02x to 0.39x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-12-31 Skr51.96 Skr1.22 x
2016-12-31 Skr1.52 Skr1.22 x
2017-12-31 Skr5.86 Skr1.22 x
2018-12-31 Skr9.83 Skr1.22 x
2019-12-31 Skr16.01 Skr1.22 x
2020-12-31 Skr11.93 Skr1.22 x
2021-12-31 Skr16.49 Skr1.22 x
2022-12-31 Skr10.09 Skr1.22 x
2023-12-31 Skr10.85 Skr1.22 x
2024-12-31 Skr8.07 Skr1.22 x
2025-12-31 Skr3.10 Skr1.22 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Iconovo utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -36.77%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -3924.34%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 1.11x
  • Recent ROE (-36.77%) is below the historical average (-18.30%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -14.31% -599.46% 0.01x 1.83x Skr-1.52 Million
2016 28.19% 17.12% 0.72x 2.30x Skr1.59 Million
2017 4.61% 7.24% 0.48x 1.34x Skr-1.70 Million
2018 -6.71% -36.06% 0.16x 1.14x Skr-10.69 Million
2019 -10.12% -93.77% 0.10x 1.05x Skr-21.89 Million
2020 -18.48% -96.30% 0.18x 1.09x Skr-26.41 Million
2021 -19.09% -169.77% 0.10x 1.08x Skr-39.86 Million
2022 -56.34% -293.93% 0.14x 1.36x Skr-59.24 Million
2023 -40.43% -648.37% 0.06x 1.13x Skr-57.25 Million
2024 -31.84% -1402.18% 0.02x 1.13x Skr-54.06 Million
2025 -36.77% -3924.34% 0.01x 1.11x Skr-55.16 Million

Industry Comparison

This section compares Iconovo's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $171,567,428
  • Average return on equity (ROE) among peers: -27.92%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Iconovo (ICO) Skr117.92 Million -14.31% 0.11x $6.94 Million
Acarix A/S (ACARIX) $15.12 Million -127.02% 0.21x $33.84 Million
Arcoma AB (ARCOMA) $48.66 Million 5.27% 0.68x $11.55 Million
Bactiguard Holding AB (publ) (BACTI-B) $387.11 Million -0.84% 0.62x $61.64 Million
BICO Group AB (BICO) $2.31 Million 0.00% 2.47x $159.82 Million
Boule Diagnostics AB (BOUL) $295.74 Million 7.87% 0.93x $14.38 Million
CellaVision AB (CEVI) $887.58 Million 17.25% 0.23x $311.10 Million
Clinical Laserthermia Systems AB (publ) (CLS-B) $26.09 Million -70.24% 0.12x $11.57 Million
Chordate Medical Holding AB (CMH) $25.64 Million -77.06% 0.22x $29.05K
C-Rad AB (publ) (CRAD-B) $29.82 Million -34.38% 0.50x $86.08 Million
Duearity AB (DEAR) $-2.39 Million 0.00% 0.00x $331.97K

About Iconovo

ST:ICO Sweden Medical Devices
Market Cap
$6.94 Million
Skr64.47 Million SEK
Market Cap Rank
#27700 Global
#613 in Sweden
Share Price
Skr1.22
Change (1 day)
+2.10%
52-Week Range
Skr1.04 - Skr2.63
All Time High
Skr95.00
Categories
Companies in Sweden Medical Devices
About

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more